Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again

Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again

Dr. Eric Topol is the editor in chief of Medscape.  He is a Cardiologist and a Geneticist with an interest in how technology affects health. Artificial Intelligence  (AI) is the ability of a digital computer or computer-controlled robot to perform tasks commonly associated with intelligent beings. AI has become the buzz word in medicine, computer science, and engineering. Machine learning, in artificial intelligence the discipline concerned with the implementation of computer software that can learn autonomously. In his latest book, ‘Deep Medicine’ Dr. Topol describes how medicine is broken today and how artificial intelligence can help make healthcare human again. Listen to this 5-minute video clip by Dr.

Hypertension guidelines: how much low?

Hypertension guidelines: how much low?

In an era that that ‘evidence-based medicine’ is facing challenges from many fronts, the benefits of blood pressure control have been shown to decrease morbidity and mortality and increase lifespan. The evidence is strong and there is no disagreement among clinicians and researchers. However, there is considerable uncertainty and debate as to how much reduction is needed in systolic blood pressure among the leading guidelines that look at the same evidence. The JNC 2018, AHA/ACC and now NICE guidelines vary with the recommendations. The page below gives the summary of guidelines available from JNC 8 (2014), ACC/AHA (2107) and ESC/ESH

Screening and General Health Checks in adults – the latest from Cochrane

Screening and General Health Checks in adults – the latest from Cochrane

Screening and prevention ‘Screening is a way of finding out if people are at higher risk of a health problem so that early treatment can be offered or information given to help them make informed decisions. Screening is a way of identifying apparently healthy people who may have an increased risk of a particular condition. The (NHS UK) offers a range of screening tests to different sections of the population. The aim is to offer screening to the people who are most likely to benefit from it. For example, some screening tests are only offered to newborn babies, while others

New Cholesterol Guidelines Personalize Risk and Add Treatments – JAMA 2019 Feb 6

New Cholesterol Guidelines Personalize Risk and Add Treatments – JAMA 2019 Feb 6

In the new guidelines, statin treatment targets are back for both primary and secondary prevention. Patients whose 10-year risk of ASCVD is 20% or more should try to reduce LDL-C levels by at least 50%, the same goal as for people with clinical ASCVD. Those with more intermediate risk should aim for at least a 30% decrease. The new update was met with considerably less controversy than the last incarnation, which deemphasized LDL-C treatment targets and introduced the AHA/ACC ASCVD risk calculator. The updated guidelines and a companion AHA/ACC special report on risk assessment tools acknowledge that the calculator estimates risk for an average

Screening for breast cancer in order to reduce the burden of breast cancer in Sri Lanka – the way forward – Is mammography an essential tool?

Screening for breast cancer in order to reduce the burden of breast cancer in Sri Lanka – the way forward – Is mammography an essential tool?

Screening for breast cancer in order to reduce the burden of breast cancer in Sri Lanka – the way forward – Is mammography an essential tool? Yes, mammography is an essential tool for screening for breast cancer. To what extent mammography reduces the burden of breast cancer will depend on the context, country and the research. The NCCP guidelines published in 2014 gives a comprehensive detail in ‘Early Detection and Management of Breast Symptoms’. This is valid even today. [Ref] Q1 Does mammography screening decrease the incidence or mortality rate from breast cancer? N0, because mammography detects breast tumours in the asymptomatic

Whole-Fat or Nonfat Dairy? The debate continues – JAMA 2018

Whole-Fat or Nonfat Dairy? The debate continues – JAMA 2018

Forty year ago US federal government recommended first recommended that everyone except young children opt for low- fat or nonfat dairy products over high-fat dairy products as part of an overall goal of reducing saturated fat intake and calories. However recent studies have suggested that high-fat milk, cheese, and yogurt are at least as healthful as their low-fat or nonfat counterparts, and their authors are questioning the wisdom of advising people to avoid whole milk and products made with it. Just as the evidence suggests that not all food sources of saturated fats—ie, animals, plants, and dairy—are the same, neither

Primary prevention with statins for older adults

Primary prevention with statins for older adults

Primary prevention remains important for adults over 65 years because significant cardiovascular morbidity after an initial event. Up to one third have a further stroke or MI or die within three years. Current guidance on lipid management in older adults is inconsistent: the National Institute for Health and Care Excellence (NICE) recommends statins for primary prevention up to age 84, the European Society of Cardiology recommends treatment to age 65, and the American Heart Association (AHA) up to age 75. For those with type 2 diabetes, NICE recommends statin prescription guided by a CVD risk calculation, whereas the AHA recommends

Why aren’t medical devices regulated like drugs? BMJ

Why aren’t medical devices regulated like drugs? BMJ

What are medical devices? Examples of medical devices include surgical lasers, wheelchairs, sutures, pacemakers, vascular grafts, intraocular lenses, and orthopedic pins. Examples of diagnostics include in vitro diagnostic reagents and test kits such as pregnancy test kits, and imaging systems such as magnetic resonance imaging (MRI). [Ref]. One of the new types that may be categorised as a ‘medical device’ is the Apple watch 4  According to the FDA, “A medical device is an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including a component part or accessory which is: recognized in the

Breast cancer screening with mammography

Breast cancer screening with mammography

Introduction In 2001, a Cochrane systematic review by Olsen & Gøtzsche [Ref] concluded that ‘The currently available reliable evidence does not show a survival benefit of mass screening for breast cancer (and the evidence is inconclusive for breast cancer mortality).  In 2013 Swiss Medical Board recommended abolishing the existing breast screening programs[Ref]. The breast screening guidelines published by the Ministry of Health (MoH) in 2014 [Ref] gives a rational evidence-based view which is valid even currently. However, in 2018 November the MoH called an expert group meeting to plan an islandwide breast screen program with the help of mobile units. One

Does the Cochrane Collaboration have the last word in Evidence? – I guess.. NO

Does the Cochrane Collaboration have the last word in Evidence? – I guess.. NO

  The HPV vaccine controversy – The background of the story…. We have to know all sides of the story before deciding what to happened and is it the truth   Prof. Peter C. Gøtzsche becomes member of the Cochrane Governing Board 2017 Message from the Governing Board – PG’s expulsion Statement from Cochrane’s Governing Board – Wednesday 26th September 2018 PG’s version as to why he was expelled BMJ SCIENCE – Evidence-based medicine group in turmoil after expulsion of co-founder The International Society for Ethical Psychology and Psychiatry announces its full support for physician Peter Gøtzsche – link PLOS BlogSpot